← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $302K of Karuna Therapeutics, Inc.

Sold$301,800
$120.72Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Fri, Oct 1. Filed Fri, Oct 1, 4:21 PM ET, after the close. Not investment advice.